Wegovy 1 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FZGF4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,324
Award facts
- Contract value 100% obligated
- $13,323.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,323.76 to AmerisourceBergen Drug Corp for the supply of Wegovy (semaglutide) 1 mg/0.5 mL pen injections on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally.
AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, serves as a critical vendor for federal medical procurement through the Defense Logistics Agency's Medical Supply Chain. The company's federal contract portfolio demonstrates extensive experience delivering brand-name and generic medications, vaccines, specialty pharmaceuticals, and medical devices across multiple therapeutic domains to support military healthcare, the Defense Health Agency, the U.S. Coast Guard, and other government medical systems. This delivery order for Wegovy, a GLP-1 receptor agonist used for weight management, reflects the company's continued role in supplying specialized medications to federal healthcare programs.
Quick answers
Who was awarded contract SPE2DB25FZGF4?
SPE2DB25FZGF4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 13, 2025.
How much is contract SPE2DB25FZGF4 worth?
The government has obligated $13,324 on SPE2DB25FZGF4.
Is contract SPE2DB25FZGF4 an order under another contract?
Yes. SPE2DB25FZGF4 is a delivery order under SPE2DB24D1107, an indefinite delivery contract.
Was contract SPE2DB25FZGF4 competed?
The extent of competition for SPE2DB25FZGF4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award